Osteoporosis and Fracture Prevention: Clinical Decision Aid

About this resource

This clinical decision aid supports family physicians in identifying patients at high fracture risk, ordering appropriate investigations and initiating evidence-based treatment in line with Osteoporosis Canada guidelines.

Use this when…

• A patient has had a fragility fracture or is at elevated risk
• You need guidance on DEXA referral criteria
• You are considering pharmacotherapy for osteoporosis

Key guidance

• Use the FRAX tool with BMD data for 10-year fracture risk assessment
• High-risk threshold: ≥20% major osteoporotic fracture or ≥3% hip fracture
• First-line treatment: oral bisphosphonates (alendronate, risedronate) for most patients
• Monitor with DEXA every 1–3 years depending on risk and treatment